Furthermore, the present study attempted to reveal whether silencing and downregulating of RIPK3 can regulate CaMKII δ alternative splicing and CaMKII activity to delay the pathogenesis of cardiac hypertrophy. The gene discussed is CAMK2G; the disease is cardiac hypertrophy.